02616 基石藥業－Ｂ
按盘价 
2.150 0.000 (0.000%) 盈利能力分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 资产回报率 (%) | -22.254% | -46.174% | -63.641% | -36.375% | -90.284% |
| 股东资金回报率 (%) | -81.053% | -108.997% | -92.280% | -44.922% | -138.058% |
| 资本运用回报率 (%) | -45.245% | -130.455% | -143.451% | -40.221% | -82.993% |
边际利润分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 毛利率 (%) | 65.603% | 57.831% | 56.166% | 76.760% | N/A |
| 未计利息、税项、折旧及摊销前利润率 (%) | -69.444% | -178.521% | -781.641% | -118.310% | N/A |
| 税前边际利润率 (%) | -79.172% | -187.525% | -787.837% | -117.536% | N/A |
| 纯利率 (%) | -79.172% | -187.525% | -787.837% | -117.536% | N/A |
变现能力分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 流动比率 (X) | 1.564 X | 1.317 X | 2.098 X | 4.913 X | 6.304 X |
| 速动比率 (X) | 1.436 X | 1.294 X | 2.033 X | 4.913 X | 6.304 X |
财务杠杆分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 总负债 / 总资产比率 (%) | 72.513% | 72.576% | 46.862% | 21.481% | 15.897% |
| 总债项 / 总资产比率 (%) | 21.868% | 17.473% | 7.669% | 2.229% | 0.147% |
| 净债项 / 总资产比率 (%) | -38.100% | -16.625% | -25.029% | -78.153% | -38.029% |
| 总债项 / 股东资金比率 (%) | 79.559% | 63.715% | 14.432% | 2.838% | 0.175% |
| 长期债项 / 股东资金比率 (%) | 49.063% | 53.719% | 10.791% | 2.455% | 0% |
| 净债项 / 股东资金比率 (%) | -138.612% | -60.623% | -47.102% | -99.534% | -45.217% |
| 净现金 / (债项) ($) | 6.33亿 | 2.72亿 | 5.69亿 | 29.41亿 | 11.22亿 |
| 每股净现金 / (债项) ($) | 0.493 | 0.227 | 0.479 | 2.505 | 1.091 |
| 总债项 / 资本运用比率 (%) | 44.778% | 41.375% | 13.014% | 2.762% | 0.174% |
| 利息盈利率 (X) | N/A | N/A | N/A | N/A | N/A |
营运效率分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 存货周转率日数 (日) | 149.864日 | 75.119日 | 209.652日 | N/A | -- |
| 应收贸易帐周转率日数 (日) | 98.194日 | 73.829日 | 176.119日 | N/A | N/A |
| 应付贸易帐周转率日数 (日) | 211.202日 | 267.177日 | 331.219日 | 11.478日 | N/A |
| 备注： | 实时报价更新时间为01/11/2024 09:24 |
| 港股实时基本市场行情由香港交易所提供; 香港交易所指定免费发放实时基本市场行情的网站。 | |
